NLS PHARMACEUTICS LTD

Historical 13F Holders

Reported Value, Excluding Options

Total Shares Held, Excluding Options

Total Filers

Each filer's latest filing for H57830137 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Lind Global Fund II LP 13G/A	4.9%	59,780	13G/A	2/14/2025 Event 12/31/2024
Lind Global Fund II LP	4.9%	59,780
Lind Global Partners II LLC	4.9%	59,780
Easton Jeff	4.9%	59,780

Period	Filers	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q3	2	144 k	$263k	$0
2025 Q2	4	161 k	$467k	$0
2025 Q1	3	169 k	$261k	$0
2024 Q4	3	152 k	$321k	$0
2024 Q3	3	148 k	$752k	$0